October 30, 2018 – "Obviousness Standard: Leveraging Latest PTO and Court Guidance — Overcoming Challenges of Obviousness and Attacks on Patent Validity" (Strafford) – 1:00 to 2:30 pm (EDT)

October 30, 2018 – European biotech patent law update (D Young & Co) – 5:00 am, 8:00 am, and 1:00 pm (EDT)

October 30, 2018 – "University Technology Transfer and Licensing Agreements — Determining Type of Transfer Agreement to Use, Structuring Key Provisions, Overcoming Unique Challenges" (Strafford) – 1:00 to 2:30 pm (EDT)

October 31, 2018 – "AIA Estoppel: A New Flavor of Collateral Estoppel and/or Res Judicata?" (Intellectual Property Owners Association) – 2:00 to 3:00 pm (ET)

November 1, 2018 – "When Patents Go Wrong . . . And What To Do About It" (J A Kemp) – 3:30 to 4:30 pm (Greenwich Mean Time)

November 7, 2018 – "Antibody Patenting After Amgen v. Sanofi: U.S. and European Perspectives — Meeting Written Description and Obviousness Requirements" (Strafford) – 1:00 to 2:30 pm (EST)

November 8, 2018 – "Deciphering the PTAB's Standard Operating Procedure Changes: A Game Changer for Post-Grant Proceedings" (Technology Transfer Tactics) – 1:00 pm to 2:00 pm (ET)